Advanced non-viral gene delivery systems are expanding the range of indications and therapy modalities possible for the new generation of genetic medicines.

Bacteria fend off invading viruses with molecular scissors that slice up viral DNA — a system called CRISPR that's become indispensable to gene ...

Non-viral gene therapies may ease some safety, pricing and manufacturing challenges linked to viral vectors, but experts say both approaches will still have a place.

CRISPR Therapeutics (Nasdaq: CRSP) today reported financial results for the first quarter ended March 31, 2026. “The first ...

Before trying to rewind the clock on aging, the best longevity approach for the most people may be preventing and treating ...

Eascra Biotech, a nanomedicine startup, has named Dr. Anne Yau, Ph.D., as a Life Science Research Scientist. Dr. Yau will be ...

Hosted virtual Analyst Day showcasing lead program KRRO-121’s potential to be a first-in-class transformational treatment for hyperammonemia in patients with urea cycle disorders (UCDs) and hepatic ...

Julia Bauman creates engaging short-form TikTok videos that make science topics accessible to a broad audience.

Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), announced that it ...

Ming, Professor of the Department of Chemical and Biological Engineering (CBE) at The Hong Kong University of Science and ...

New CRISPR paradigm: HKUST scientists created a DNA-guided Cas12a system that targets RNA, reversing the traditional RNA-guided DNA targeting model. Clinical potential: The SLEUTH platform ...

After a large trial showed stronger protection, regulators are weighing whether Moderna’s mRNA vaccine could become a U.S.